Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 44 out of 100. Disparities

Topic: Risk, prevention and care in population studies

Plain-language summary

Medicare beneficiaries who received an AWV were 13% to 21% more likely than those without an AWV to be diagnosed at MCI stage versus ADRD stage. The interaction effect of AWV, sex, and race/ethnicity on MCI diagnosis was significant. The likelihood of MCI diagnosis versus ADRD was similar between females and males among those who received AWVs. Receiving an AWV reduced, but did not eliminate, racial/ethnic differences in MCI diagnosis. AWVs had modest but significant effects in reducing disparity in the diagnosis of early cognitive impairment. Highlights: Data from analyses of Medicare beneficiaries newly diagnosed with mild cognitive impairment/Alzheimer's disease and related dementias suggested a positive association between Annual Wellness Visit (AWV) use and early diagnosis of cognitive impairment (CI).AWVs had modest but significant effects in reducing the sex and racial/ethnic disparity in early CI diagnosis.Further studies, including on cognition assessment, caregivers' preferences for AWVs, and the ways in which providers deliver AWVs, will help us better understand the effect of AWVs on reducing disparities in early dementia diagnosis.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Kuo, Y., Tzeng, H., Shan, Y., & Raji, M. A. (2025). Can annual wellness visits reduce disparity in early dementia diagnosis? Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. https://doi.org/10.1002/dad2.70114

Vancouver

Kuo Y, Tzeng H, Shan Y, Raji MA. Can annual wellness visits reduce disparity in early dementia diagnosis? Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 2025. doi:10.1002/dad2.70114. PMID: 40357141.

BibTeX

@article{kuo2025-40357141,
  author  = {Kuo, Yong‐Fang and Tzeng, Huey‐Ming and Shan, Yong and Raji, Mukaila A.},
  title   = {{Can annual wellness visits reduce disparity in early dementia diagnosis?}},
  journal = {Alzheimer s \& Dementia Diagnosis Assessment \& Disease Monitoring},
  year    = {2025},
  doi     = {10.1002/dad2.70114},
  pmid    = {40357141},
  url     = {https://doi.org/10.1002/dad2.70114}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that Medicare beneficiaries who received an annual wellness visit were 13% to 21% more likely to be diagnosed at the mild cognitive impairment stage rather than the dementia stage. Annual wellness visits reduced, but did not eliminate, racial and ethnic differences in early diagnosis.

Study details

How this study scored 44/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 6 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 44 of 100.44 of 100 points earned56 not earned

Published in a peer-reviewed journal, and it is a case-control study. Scored zero for effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring)
Journal's citation record 1 / 4 Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring: journal h-index 86 (OpenAlex, 2026-10-29)
Study design 6 / 12 A case-control study
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 100 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Mukaila A. Raji: h-index 47 (OpenAlex, whole career)
Institution's track record 0 / 3 The University of Texas Medical Branch at Galveston: institution h-index 655 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40357141)
Free to read 2 / 2 Free to read
Total 44 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Disparities from nearby years

Also tagged “prevalence”

1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Disparities

See all studies in Disparities →